Topic: lung disease

Paul Streck, M.D., will this week exit his role as chief medical officer of Insmed to “pursue an employment opportunity on the West Coast.”

A rare cell type, discovered by two teams and named as "pulmonary ionocyte," appears to help drive cystic fibrosis.

4D will use its AAV vectors to create therapies that insert genes that code for therapeutic proteins into human cells.

Scientists have amassed evidence that the metformin's ability to target cell metabolism could help repair the lung.

An FDA advisory committee panel voted against recommending premarket approval for PneumRx’s Elevair lung implant for patients with severe emphysema.

The biotech is now testing product batches to assess whether the formulation is to blame for the lackluster data.

The results come from a small, exploratory study Reata initiated after wrapping up a trial of the drug in its primary indication.

The past week ushered in news about a toxin in scorpion venom that may relieve RA and a skin bacterium with anti-cancer powers.

Aradigm's CEO, chief medical officer and chief financial officer resigned.

Data from the phase 2a trial suggest Verona’s PDE3/PDE4 inhibitor may complement long-acting muscarinic antagonist bronchodilators such as Spiriva.